After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...
Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...
Replay the call for the latest insights. Chart does not reflect overnight price.
A 1 mW 71.5 dB SNDR 50 MS/s 13 bit Fully Differential Ring Amplifier Based SAR-Assisted Pipeline ADC
Abstract: This paper presents a 13 bit 50 MS/s fully differential ring amplifier based SAR-assisted pipeline ADC, implemented in 65 nm CMOS. We introduce a new fully differential ring amplifier, which ...
Antibody–drug conjugates (ADCs) combine the targeting ability of monoclonal antibodies with the cell-killing effects of potent cytotoxic drugs. Over the past decade, the approach has moved from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results